Elaine Morrato
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antipsychotic Agents | 15 | 2021 | 197 | 5.310 |
Why?
| Medicaid | 14 | 2022 | 416 | 2.790 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 7 | 2021 | 240 | 2.170 |
Why?
| Schizophrenia | 6 | 2021 | 544 | 1.900 |
Why?
| Blood Glucose | 11 | 2016 | 1957 | 1.600 |
Why?
| Lipids | 6 | 2016 | 614 | 1.490 |
Why?
| United States Food and Drug Administration | 10 | 2023 | 186 | 1.410 |
Why?
| Risk Management | 4 | 2020 | 94 | 1.330 |
Why?
| Practice Patterns, Physicians' | 12 | 2017 | 1267 | 1.270 |
Why?
| Developmental Disabilities | 2 | 2020 | 257 | 1.130 |
Why?
| United States | 42 | 2023 | 13272 | 1.100 |
Why?
| Risk Evaluation and Mitigation | 2 | 2021 | 2 | 1.020 |
Why?
| Prescription Drugs | 3 | 2022 | 113 | 1.000 |
Why?
| Diabetes Mellitus | 8 | 2021 | 985 | 0.990 |
Why?
| Missouri | 8 | 2016 | 65 | 0.980 |
Why?
| Pharmaceutical Preparations | 3 | 2023 | 168 | 0.960 |
Why?
| Mental Disorders | 7 | 2015 | 952 | 0.860 |
Why?
| State Government | 1 | 2022 | 43 | 0.830 |
Why?
| Drug Prescriptions | 5 | 2016 | 271 | 0.820 |
Why?
| Mass Screening | 4 | 2016 | 1095 | 0.800 |
Why?
| Risk Assessment | 7 | 2023 | 3213 | 0.780 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2022 | 116 | 0.780 |
Why?
| Insurance Coverage | 1 | 2022 | 218 | 0.740 |
Why?
| Depression, Postpartum | 1 | 2022 | 103 | 0.730 |
Why?
| Caregivers | 3 | 2022 | 723 | 0.660 |
Why?
| Comparative Effectiveness Research | 3 | 2014 | 142 | 0.660 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2009 | 37 | 0.650 |
Why?
| State Health Plans | 2 | 2016 | 31 | 0.650 |
Why?
| Stroke Rehabilitation | 1 | 2018 | 35 | 0.640 |
Why?
| Program Evaluation | 3 | 2023 | 880 | 0.640 |
Why?
| Periodontal Diseases | 2 | 2015 | 58 | 0.630 |
Why?
| Humans | 68 | 2023 | 122796 | 0.620 |
Why?
| Child Health Services | 1 | 2019 | 180 | 0.610 |
Why?
| Physician-Patient Relations | 2 | 2014 | 509 | 0.580 |
Why?
| Drug Utilization Review | 2 | 2014 | 65 | 0.570 |
Why?
| Community Mental Health Services | 2 | 2016 | 84 | 0.560 |
Why?
| Community Mental Health Centers | 1 | 2015 | 15 | 0.550 |
Why?
| Information Dissemination | 2 | 2015 | 225 | 0.540 |
Why?
| Paliperidone Palmitate | 1 | 2014 | 4 | 0.520 |
Why?
| Advisory Committees | 4 | 2012 | 229 | 0.500 |
Why?
| Quality Control | 1 | 2014 | 165 | 0.490 |
Why?
| Dyslipidemias | 3 | 2010 | 165 | 0.490 |
Why?
| Bipolar Disorder | 1 | 2016 | 207 | 0.490 |
Why?
| Risk | 2 | 2018 | 890 | 0.480 |
Why?
| Cohort Studies | 12 | 2020 | 5294 | 0.470 |
Why?
| Patient Care | 1 | 2014 | 117 | 0.470 |
Why?
| Physicians' Offices | 1 | 2012 | 17 | 0.450 |
Why?
| Health Services Research | 2 | 2015 | 380 | 0.450 |
Why?
| Universities | 1 | 2015 | 356 | 0.440 |
Why?
| Diabetes Mellitus, Type 2 | 5 | 2011 | 2221 | 0.440 |
Why?
| Focus Groups | 1 | 2014 | 391 | 0.440 |
Why?
| Physician's Role | 1 | 2014 | 207 | 0.440 |
Why?
| Malpractice | 1 | 2012 | 42 | 0.430 |
Why?
| Primary Health Care | 3 | 2020 | 1625 | 0.430 |
Why?
| Injections | 3 | 2021 | 171 | 0.430 |
Why?
| Anti-Obesity Agents | 1 | 2012 | 49 | 0.430 |
Why?
| Drug Approval | 1 | 2012 | 80 | 0.420 |
Why?
| Parents | 2 | 2019 | 1256 | 0.420 |
Why?
| Drug Monitoring | 2 | 2010 | 189 | 0.410 |
Why?
| Female | 31 | 2022 | 63629 | 0.400 |
Why?
| Adolescent | 21 | 2016 | 18948 | 0.390 |
Why?
| Patient Safety | 1 | 2014 | 302 | 0.390 |
Why?
| Adult | 21 | 2022 | 32385 | 0.390 |
Why?
| Health Care Costs | 1 | 2014 | 414 | 0.390 |
Why?
| Quality Improvement | 4 | 2020 | 1004 | 0.380 |
Why?
| Multivariate Analysis | 7 | 2015 | 1531 | 0.370 |
Why?
| Retrospective Studies | 15 | 2020 | 13433 | 0.370 |
Why?
| Hospitalization | 3 | 2014 | 1914 | 0.360 |
Why?
| Middle Aged | 18 | 2022 | 28563 | 0.360 |
Why?
| Hyperglycemia | 2 | 2011 | 326 | 0.360 |
Why?
| Male | 29 | 2021 | 59639 | 0.360 |
Why?
| Polypharmacy | 2 | 2007 | 78 | 0.350 |
Why?
| Managed Care Programs | 3 | 2009 | 154 | 0.350 |
Why?
| Databases, Factual | 8 | 2014 | 1287 | 0.350 |
Why?
| Medication Adherence | 1 | 2014 | 575 | 0.350 |
Why?
| Risk Factors | 13 | 2015 | 9381 | 0.340 |
Why?
| Hyperlipidemias | 1 | 2010 | 134 | 0.340 |
Why?
| Insurance Claim Review | 2 | 2021 | 70 | 0.340 |
Why?
| Cardiovascular Diseases | 4 | 2015 | 1859 | 0.330 |
Why?
| Administration, Oral | 3 | 2016 | 786 | 0.330 |
Why?
| Practice Guidelines as Topic | 2 | 2014 | 1519 | 0.320 |
Why?
| General Surgery | 2 | 2013 | 146 | 0.310 |
Why?
| Logistic Models | 5 | 2015 | 1995 | 0.310 |
Why?
| Neoplasms | 4 | 2023 | 2235 | 0.310 |
Why?
| Delayed-Action Preparations | 2 | 2021 | 162 | 0.300 |
Why?
| Office Visits | 1 | 2007 | 94 | 0.300 |
Why?
| Pemoline | 1 | 2007 | 5 | 0.300 |
Why?
| Policy Making | 1 | 2007 | 91 | 0.300 |
Why?
| Emergency Medical Services | 1 | 2014 | 635 | 0.300 |
Why?
| Dementia | 2 | 2021 | 211 | 0.290 |
Why?
| Cross-Sectional Studies | 5 | 2023 | 4734 | 0.280 |
Why?
| Data Collection | 3 | 2008 | 667 | 0.280 |
Why?
| Health Policy | 3 | 2007 | 356 | 0.280 |
Why?
| Electronic Health Records | 1 | 2012 | 842 | 0.270 |
Why?
| Metabolic Syndrome | 2 | 2011 | 395 | 0.270 |
Why?
| Exercise | 2 | 2007 | 1743 | 0.270 |
Why?
| Physical Fitness | 1 | 2007 | 184 | 0.270 |
Why?
| Guideline Adherence | 1 | 2010 | 560 | 0.270 |
Why?
| Child | 17 | 2022 | 19561 | 0.260 |
Why?
| California | 4 | 2010 | 387 | 0.260 |
Why?
| Fee-for-Service Plans | 3 | 2021 | 94 | 0.250 |
Why?
| Medicare | 2 | 2021 | 767 | 0.240 |
Why?
| Drug Labeling | 3 | 2010 | 48 | 0.240 |
Why?
| Communication | 3 | 2022 | 776 | 0.240 |
Why?
| Young Adult | 9 | 2016 | 11094 | 0.240 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2015 | 3388 | 0.240 |
Why?
| Diabetes Complications | 4 | 2011 | 226 | 0.230 |
Why?
| Obesity | 3 | 2012 | 2786 | 0.230 |
Why?
| Evidence-Based Medicine | 1 | 2007 | 731 | 0.230 |
Why?
| Small-Area Analysis | 2 | 2014 | 10 | 0.230 |
Why?
| Specialties, Surgical | 3 | 2013 | 76 | 0.230 |
Why?
| Infant | 5 | 2020 | 8523 | 0.220 |
Why?
| Aged, 80 and over | 8 | 2018 | 6845 | 0.220 |
Why?
| Aged | 13 | 2021 | 20495 | 0.200 |
Why?
| Diffusion of Innovation | 2 | 2013 | 97 | 0.200 |
Why?
| Treatment Outcome | 5 | 2021 | 9692 | 0.200 |
Why?
| Age Factors | 4 | 2019 | 3114 | 0.200 |
Why?
| Stakeholder Participation | 1 | 2022 | 68 | 0.200 |
Why?
| Mental Status and Dementia Tests | 1 | 2021 | 24 | 0.200 |
Why?
| Child, Preschool | 7 | 2019 | 9755 | 0.190 |
Why?
| Public Health | 3 | 2023 | 480 | 0.190 |
Why?
| Spinal Fusion | 2 | 2013 | 226 | 0.180 |
Why?
| Oregon | 2 | 2010 | 72 | 0.180 |
Why?
| Information Storage and Retrieval | 1 | 2020 | 131 | 0.170 |
Why?
| Mentors | 2 | 2023 | 170 | 0.170 |
Why?
| Nootropic Agents | 1 | 2018 | 28 | 0.170 |
Why?
| Surgical Procedures, Operative | 2 | 2013 | 227 | 0.160 |
Why?
| Delivery of Health Care | 2 | 2023 | 915 | 0.160 |
Why?
| Medicare Part D | 1 | 2018 | 28 | 0.160 |
Why?
| Professional-Family Relations | 1 | 2019 | 141 | 0.160 |
Why?
| Recurrence | 1 | 2021 | 998 | 0.160 |
Why?
| Pediatrics | 4 | 2017 | 1009 | 0.160 |
Why?
| Health Services Accessibility | 2 | 2022 | 813 | 0.160 |
Why?
| Social Networking | 1 | 2018 | 37 | 0.150 |
Why?
| Time-to-Treatment | 1 | 2019 | 157 | 0.150 |
Why?
| Severity of Illness Index | 2 | 2019 | 2784 | 0.150 |
Why?
| Checklist | 1 | 2018 | 84 | 0.150 |
Why?
| Drug and Narcotic Control | 2 | 2007 | 27 | 0.150 |
Why?
| Curriculum | 2 | 2015 | 925 | 0.150 |
Why?
| Suicide | 3 | 2007 | 498 | 0.150 |
Why?
| Health Priorities | 1 | 2017 | 36 | 0.150 |
Why?
| Odds Ratio | 3 | 2015 | 1043 | 0.150 |
Why?
| Preventive Health Services | 1 | 2018 | 144 | 0.140 |
Why?
| Evidence-Based Practice | 1 | 2018 | 195 | 0.140 |
Why?
| Cancer Survivors | 1 | 2021 | 225 | 0.140 |
Why?
| Mental Health | 3 | 2011 | 571 | 0.140 |
Why?
| Monitoring, Physiologic | 2 | 2009 | 288 | 0.140 |
Why?
| Urban Population | 1 | 2019 | 425 | 0.140 |
Why?
| Indians, North American | 1 | 2021 | 597 | 0.140 |
Why?
| Birth Weight | 1 | 2019 | 473 | 0.140 |
Why?
| Case Management | 1 | 2015 | 65 | 0.130 |
Why?
| Hospitals, Pediatric | 3 | 2013 | 507 | 0.130 |
Why?
| Societies, Medical | 2 | 2010 | 741 | 0.130 |
Why?
| Poverty | 1 | 2019 | 475 | 0.130 |
Why?
| Referral and Consultation | 1 | 2020 | 669 | 0.130 |
Why?
| Patient-Centered Care | 3 | 2018 | 513 | 0.130 |
Why?
| Spatial Analysis | 1 | 2014 | 28 | 0.130 |
Why?
| Analgesics, Opioid | 1 | 2022 | 785 | 0.120 |
Why?
| Time Factors | 3 | 2014 | 6682 | 0.120 |
Why?
| Research Support as Topic | 1 | 2015 | 122 | 0.120 |
Why?
| Hospitals, General | 1 | 2013 | 18 | 0.120 |
Why?
| Prevalence | 4 | 2008 | 2442 | 0.120 |
Why?
| Home Nursing | 1 | 2013 | 28 | 0.110 |
Why?
| Patient Care Team | 1 | 2018 | 520 | 0.110 |
Why?
| Bias | 1 | 2014 | 207 | 0.110 |
Why?
| Insurance, Liability | 1 | 2012 | 7 | 0.110 |
Why?
| Organizational Objectives | 1 | 2013 | 68 | 0.110 |
Why?
| Socioeconomic Factors | 3 | 2018 | 1158 | 0.110 |
Why?
| Healthcare Disparities | 1 | 2018 | 494 | 0.110 |
Why?
| Organizational Case Studies | 1 | 2012 | 75 | 0.110 |
Why?
| Liability, Legal | 1 | 2012 | 45 | 0.110 |
Why?
| Attitude of Health Personnel | 1 | 2019 | 1012 | 0.110 |
Why?
| Classification | 1 | 2012 | 29 | 0.110 |
Why?
| Oral Hygiene | 1 | 2011 | 16 | 0.100 |
Why?
| Mentally Ill Persons | 1 | 2011 | 13 | 0.100 |
Why?
| Disease Management | 1 | 2015 | 591 | 0.100 |
Why?
| Models, Organizational | 1 | 2012 | 144 | 0.100 |
Why?
| Sex Factors | 2 | 2007 | 1860 | 0.100 |
Why?
| Fundoplication | 1 | 2011 | 56 | 0.100 |
Why?
| Laparotomy | 1 | 2011 | 109 | 0.100 |
Why?
| Interprofessional Relations | 1 | 2013 | 271 | 0.090 |
Why?
| Educational Status | 3 | 2011 | 448 | 0.090 |
Why?
| Interviews as Topic | 1 | 2013 | 601 | 0.090 |
Why?
| Biomedical Research | 1 | 2017 | 630 | 0.090 |
Why?
| Matched-Pair Analysis | 1 | 2010 | 42 | 0.090 |
Why?
| Triglycerides | 2 | 2011 | 527 | 0.090 |
Why?
| Body Mass Index | 3 | 2007 | 2144 | 0.090 |
Why?
| Perception | 1 | 2012 | 324 | 0.090 |
Why?
| Specialization | 2 | 2007 | 134 | 0.090 |
Why?
| Pregnancy | 1 | 2022 | 5854 | 0.090 |
Why?
| Benchmarking | 1 | 2011 | 184 | 0.090 |
Why?
| Consensus Development Conferences as Topic | 1 | 2009 | 31 | 0.090 |
Why?
| Medicine | 2 | 2007 | 112 | 0.090 |
Why?
| Patient Satisfaction | 1 | 2013 | 632 | 0.080 |
Why?
| Glucose Tolerance Test | 1 | 2010 | 370 | 0.080 |
Why?
| Surgical Wound Infection | 1 | 2011 | 251 | 0.080 |
Why?
| Tennessee | 1 | 2008 | 45 | 0.080 |
Why?
| Utah | 1 | 2008 | 64 | 0.080 |
Why?
| Legislation, Medical | 1 | 2007 | 10 | 0.080 |
Why?
| Medical Audit | 1 | 2008 | 78 | 0.080 |
Why?
| State Medicine | 1 | 2007 | 22 | 0.080 |
Why?
| Psychotic Disorders | 1 | 2010 | 154 | 0.080 |
Why?
| Health Surveys | 2 | 2007 | 468 | 0.080 |
Why?
| Comorbidity | 2 | 2010 | 1600 | 0.080 |
Why?
| Risk Adjustment | 1 | 2008 | 83 | 0.080 |
Why?
| Evaluation Studies as Topic | 1 | 2007 | 190 | 0.080 |
Why?
| Appointments and Schedules | 1 | 2007 | 80 | 0.080 |
Why?
| Clozapine | 1 | 2007 | 21 | 0.070 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| Cholesterol | 1 | 2009 | 380 | 0.070 |
Why?
| United Kingdom | 1 | 2007 | 260 | 0.070 |
Why?
| Australia | 1 | 2007 | 223 | 0.070 |
Why?
| Laparoscopy | 1 | 2011 | 426 | 0.070 |
Why?
| Product Surveillance, Postmarketing | 1 | 2007 | 70 | 0.070 |
Why?
| Waiting Lists | 1 | 2007 | 229 | 0.070 |
Why?
| Immunization Programs | 1 | 2007 | 210 | 0.070 |
Why?
| Follow-Up Studies | 3 | 2011 | 4768 | 0.070 |
Why?
| Decision Making | 1 | 2012 | 840 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2008 | 362 | 0.070 |
Why?
| Central Nervous System Stimulants | 1 | 2007 | 143 | 0.070 |
Why?
| Depressive Disorder | 1 | 2007 | 347 | 0.060 |
Why?
| Depressive Disorder, Major | 1 | 2007 | 309 | 0.060 |
Why?
| Drug Therapy, Combination | 1 | 2007 | 988 | 0.060 |
Why?
| Coronary Disease | 1 | 2006 | 372 | 0.060 |
Why?
| Proportional Hazards Models | 1 | 2007 | 1184 | 0.060 |
Why?
| Incidence | 1 | 2010 | 2527 | 0.060 |
Why?
| Quality of Health Care | 1 | 2008 | 631 | 0.060 |
Why?
| Diabetic Angiopathies | 1 | 2005 | 270 | 0.060 |
Why?
| Counseling | 1 | 2006 | 364 | 0.060 |
Why?
| Colorado | 1 | 2012 | 4325 | 0.050 |
Why?
| South Carolina | 2 | 2011 | 37 | 0.050 |
Why?
| Alaska | 1 | 2021 | 85 | 0.050 |
Why?
| Patient Education as Topic | 1 | 2006 | 717 | 0.050 |
Why?
| Postoperative Complications | 2 | 2011 | 2301 | 0.050 |
Why?
| Survivorship | 1 | 2021 | 38 | 0.050 |
Why?
| Substance-Related Disorders | 1 | 2009 | 958 | 0.050 |
Why?
| Medical Oncology | 1 | 2022 | 231 | 0.050 |
Why?
| Europe | 1 | 2020 | 369 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 4882 | 0.040 |
Why?
| Students | 1 | 2023 | 529 | 0.040 |
Why?
| Independent Living | 1 | 2018 | 90 | 0.040 |
Why?
| Residence Characteristics | 1 | 2018 | 313 | 0.030 |
Why?
| Pharmacoepidemiology | 1 | 2015 | 22 | 0.030 |
Why?
| Health Promotion | 1 | 2022 | 707 | 0.030 |
Why?
| Global Health | 1 | 2015 | 352 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 573 | 0.030 |
Why?
| Health Planning Guidelines | 1 | 2012 | 26 | 0.030 |
Why?
| Radiography, Bitewing | 1 | 2011 | 2 | 0.030 |
Why?
| Gingival Hemorrhage | 1 | 2011 | 3 | 0.030 |
Why?
| Dental Devices, Home Care | 1 | 2011 | 4 | 0.030 |
Why?
| Toothbrushing | 1 | 2011 | 5 | 0.030 |
Why?
| Alveolar Bone Loss | 1 | 2011 | 10 | 0.030 |
Why?
| Periodontal Attachment Loss | 1 | 2011 | 11 | 0.030 |
Why?
| Mouthwashes | 1 | 2011 | 12 | 0.030 |
Why?
| Xerostomia | 1 | 2011 | 18 | 0.030 |
Why?
| Dental Care | 1 | 2011 | 28 | 0.030 |
Why?
| Accreditation | 1 | 2012 | 96 | 0.030 |
Why?
| Chronic Disease | 1 | 2018 | 1645 | 0.030 |
Why?
| Certification | 1 | 2012 | 110 | 0.020 |
Why?
| Income | 1 | 2011 | 181 | 0.020 |
Why?
| Confidence Intervals | 1 | 2011 | 339 | 0.020 |
Why?
| Community Networks | 1 | 2011 | 54 | 0.020 |
Why?
| C-Peptide | 1 | 2011 | 137 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 416 | 0.020 |
Why?
| Infant, Newborn | 2 | 2013 | 5430 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 564 | 0.020 |
Why?
| Pain Measurement | 1 | 2011 | 481 | 0.020 |
Why?
| Qualitative Research | 1 | 2013 | 950 | 0.020 |
Why?
| Regression Analysis | 1 | 2011 | 1018 | 0.020 |
Why?
| Statistics as Topic | 1 | 2009 | 314 | 0.020 |
Why?
| Population Surveillance | 1 | 2011 | 439 | 0.020 |
Why?
| Education, Medical, Graduate | 1 | 2012 | 432 | 0.020 |
Why?
| Mental Health Services | 1 | 2011 | 329 | 0.020 |
Why?
| Patient Discharge | 1 | 2013 | 842 | 0.020 |
Why?
| National Health Programs | 1 | 2006 | 23 | 0.020 |
Why?
| Drug Utilization | 1 | 2007 | 183 | 0.020 |
Why?
| Length of Stay | 1 | 2011 | 1077 | 0.020 |
Why?
| Pilot Projects | 1 | 2011 | 1477 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 731 | 0.020 |
Why?
| Quality Indicators, Health Care | 1 | 2008 | 315 | 0.020 |
Why?
| Physicians, Family | 1 | 2007 | 242 | 0.020 |
Why?
| Seasons | 1 | 2007 | 468 | 0.020 |
Why?
| Clinical Competence | 1 | 2012 | 973 | 0.020 |
Why?
| Survival Analysis | 1 | 2008 | 1325 | 0.020 |
Why?
| Psychiatry | 1 | 2007 | 205 | 0.010 |
Why?
| Survival Rate | 1 | 2008 | 1810 | 0.010 |
Why?
| Life Style | 1 | 2005 | 436 | 0.010 |
Why?
| Motor Activity | 1 | 2005 | 679 | 0.010 |
Why?
| Prospective Studies | 1 | 2011 | 6704 | 0.010 |
Why?
|
|
Morrato's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|